Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Amsterdam UMC
- University of Exeter
- CNRS
- University of North Carolina at Chapel Hill
- KNAW
- Sanquin Blood Supply Foundation (Sanquin)
- The University of Iowa
- University of Bergen
- Forschungszentrum Jülich
- Karl Landsteiner University of Health Sciences
- Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg
- Monash University
- Radboud University
- Universitat de Barcelona
- University of Bath
- Utrecht University
- AITHYRA GmbH - Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences
- Aalborg University
- Columbia University
- Curtin University
- Delft University of Technology (TU Delft)
- Duke University
- ETH Zürich
- European Magnetism Association EMA
- Hannover Medical School
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- ICN2
- IDAEA-CSIC
- Institut Pasteur
- Institute of Neurosciences
- International PhD Programme (IPP) Mainz
- King's College London;
- LASE (University of Kent)
- Leibniz Institute for Natural Product Research and Infection Biology
- Leipzig University •
- Ludwig-Maximilians-Universität München •
- MASARYK UNIVERSITY
- Maastricht University (UM)
- Max Planck Institute for Biological Cybernetics, Tübingen
- Medical University of Graz
- Newcastle University
- Prinses Máxima Centrum
- Purdue University
- Radboud University Medical Center (Radboudumc)
- St. Anna Kinderkrebsforschung e.V.
- THE UNIVERSITY OF HONG KONG
- Technische Universität Berlin •
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- University Medical Center Groningen
- University of Amsterdam (UvA)
- University of Bedfordshire
- University of Groningen
- University of Louisville
- University of Oldenburg •
- University of Oxford
- University of Reading
- University of Texas Health Science Center San Antonio
- University of Texas at El Paso
- 48 more »
- « less
-
Field
-
disrupted in neurodevelopmental disorders. These studentships are funded through GW4 BioMed3 MRC Doctoral Landscape Programme and consist of UK tuition fees, as well as a Doctoral Stipend matching UK Research
-
disorders will be correlated with pain phenotypes to determine underlying mechanisms that predict susceptibility to pain. These studentships are funded through GW4 BioMed3 MRC Doctoral Landscape Programme and
-
to build the developing brain? This project explores how neuronal signals regulate astrocyte function and how this communication is disrupted in neurodevelopmental disorders. Using a unique combination of
-
to the development of age-related hematological disorders. This PhD project aims to understand the molecular mechanisms underlying HSC senescence and functional aging, as well as their consequences for hematopoiesis
-
) light-driven chemical synthesis The Extraction of Critical Minerals from Seawater by Porous Polymers Cool by Design: Harnessing Disorder for Solid-State Cooling Designing bespoke Raman active chemical
-
mental disorder. Given this, transdiagnostic interventions that target shared underlying processes (e.g., dysregulated emotions, negative self-beliefs) could be appropriate but remain underexplored. Many
-
of synaptic function. We are also interested in understanding how disruption of these mechanisms may contribute to neurological disorders. The successful candidate will join a multidisciplinary research
-
, Psycholinguistics, or Clinical Language Science. The School has particular strength in psychopathology and emotional disorders, affective and cognitive neuroscience, personalised nutrition, motivation and behaviour
-
POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's
-
The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences | Poland | about 1 month ago
Postdoctoral fellow in the group of Prof. Peter G. Schultz at Scripps Research in La Jolla on the reprogramming of Botulinum proteases for targeted degradation of intrinsically disordered proteins